[Federal Register Volume 80, Number 195 (Thursday, October 8, 2015)]
[Notices]
[Pages 60897-60898]
[FR Doc No: 2015-25687]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2015-0669; FRL-9934-99]

Pesticide Program Dialogue Committee; Notice of Public Meeting

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Federal Advisory Committee Act, the
Environmental Protection Agency's Office of Pesticide Programs is
announcing a public meeting of the Pesticide Program Dialogue Committee
(PPDC) on October 21-22, 2015. In addition, EPA is announcing meetings
on October 20, 2015, of the following PPDC Workgroups: Integrated Pest
Management, Comparative Safety Statements, 21st Century Toxicology/New
Integrated Testing Strategies, and Pesticide Incidents. These meetings
provide advice and recommendations to the EPA Administrator on issues
associated with pesticide regulatory development and reform
initiatives, evolving public policy and program implementation issues,
and science issues associated with evaluating and reducing risks from
use of pesticides.

DATES: The PPDC meeting will be held on Wednesday, October 21, 2015,
from 9 a.m. to 5:00 p.m. and Thursday, October 22, 2015, from 9 a.m. to
12:00 p.m.
    Work Group Meetings: On Tuesday, October 20, 2015, PPDC Work Group
meetings are scheduled as follows: Integrated Pest Management Work
Group, 1:00 p.m. to 3:00 p.m., Comparative Safety Statements Work
Group, 2:00 p.m. to 4:00 p.m., 21st Century Toxicology/New Integrated
Testing Strategies Work Group, 1:00 p.m. to 3:00 p.m., and Pesticide
Incidents Work Group, 1:30 p.m. to 4:00 p.m.
    Agenda: A draft agenda will be posted on or before October 7, 2015.
    Accommodations requests: To request accommodation of a disability,
please contact the person listed under FOR FURTHER INFORMATON CONTACT,
preferably at least 10 days prior to the meeting, to give EPA as much
time as possible to process your request.

ADDRESSES: The PPDC Meeting and PPDC Work Group meetings will be held
at 1 Potomac Yard South, 2777 S. Crystal Drive, Arlington, VA. The PPDC
meeting will be held in the lobby-level Conference Center. The PPDC
Work Group meetings will be held as follows: Integrated Pest Management
Work Group in the fourth floor conference room number N4850-70,
Comparative Safety Statements Work Group in the lobby-level Conference
Center; 21st Century Toxicology/New Integrated Testing Strategies Work
Group in the ninth floor conference room number 9100; and Pesticide
Incidents Work Group in the fourth floor conference room number N4830.
    EPA's Potomac Yard South Building is approximately 1 mile from the
Crystal City Metro Station.

FOR FURTHER INFORMATION CONTACT: Dea Zimmerman, Office of Pesticide
Programs (LC-8J), Environmental Protection Agency, 77 W. Jackson
Boulevard, Chicago, IL 60604; telephone number:<PHONE_NUMBER>; email
address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you work in
agricultural settings or if you are concerned about implementation of
the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); the
Federal Food, Drug, and Cosmetic Act (FFDCA); and the amendments to
both of these major pesticide laws by the Food Quality Protection Act
(FQPA) of 1996; the Pesticide Registration Improvement Act, and the
Endangered Species Act. Potentially affected entities may include, but
are not limited to: Agricultural workers and farmers; pesticide
industry and trade associations; environmental, consumer, and farm
worker groups; pesticide users and growers; animal rights groups; pest
consultants; state, local, and tribal governments; academia; public
health organizations; and the public. If you have questions regarding
the applicability of this action to a particular entity, consult the
person listed under FOR FURTHER INFORMATION CONTACT.

B. How can I get copies of this document and other related information?

    The docket for this action, identified by docket identification
(ID) number EPA-HQ-OPP-2015-0669 is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW., Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is<PHONE_NUMBER>, the telephone number for the OPP Docket
is<PHONE_NUMBER>. Please review the visitor instructions and
additional information about the docket available at http://www.epa.gov/dockets.

II. Background

    The PPDC is a Federal advisory committee chartered under the
Federal Advisory Committee Act (FACA), Public Law 92-463. EPA
established the PPDC in September 1995 to provide advice and
recommendations to the EPA Administrator on issues associated with
pesticide regulatory development and reform initiatives, evolving
public policy and program implementation issues, and science issues
associated with evaluating and reducing risks from use of pesticides.
The following sectors are represented on the current PPDC:
Environmental/public interest and animal rights groups; farm worker
organizations; pesticide industry and trade associations; pesticide
user, grower, and commodity groups; Federal and state/local/tribal
governments; the general public; academia; and public health
organizations.

III. How can I request to participate in this meeting?

    PPDC meetings are free, open to the public, and no advance
registration is required. Public comments may be made during the public
comment session of each meeting or in writing to the person listed
under FOR FURTHER INFORMATION CONTACT.

    Authority: 7 U.S.C. 136 et seq.

    Dated: October 2, 2015.
 Marty Monell,
Acting Director, Office of Pesticide Programs.
[FR Doc. 2015-25687 Filed 10-7-15; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 83, Number 101 (Thursday, May 24, 2018)]
[Notices]
[Pages 24130-24131]
[FR Doc No: 2018-11166]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-1797]

Joint Meeting of the Anesthetic and Analgesic Drug Products
Advisory Committee and the Drug Safety and Risk Management Advisory
Committee; Notice of Meeting; Establishment of a Public Docket; Request
for Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; establishment of a public docket; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) announces a forthcoming
public advisory committee meeting of the Anesthetic and Analgesic Drug
Products Advisory Committee and the Drug Safety and Risk Management
Advisory Committee. The general function of the committees is to
provide advice and recommendations to FDA on regulatory issues. At
least one portion of the meeting will be closed to the public. FDA is
establishing a docket for public comment on this document.

DATES: The meeting will be held on June 26, 2018, from 8 a.m. to 5 p.m.

ADDRESSES: DoubleTree by Hilton Hotel Bethesda--Washington DC, Grand
Ballroom, 8120 Wisconsin Ave., Bethesda, MD 20814-3624. The conference
center's telephone number is<PHONE_NUMBER>. Answers to commonly asked
questions about FDA Advisory Committee meetings including information
regarding special accommodations due to a disability, visitor parking,
and transportation may be accessed at: https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm408555.htm. Information
about the DoubleTree by Hilton Hotel Bethesda--Washington DC Conference
Center can be accessed at: http://doubletree3.hilton.com/en/hotels/maryland/doubletree-by-hilton-hotel-bethesda-washington-dc-WASBHDT/index.html.
    FDA is establishing a docket for public comment on this meeting.
The docket number is FDA-2018-N-1797. The docket will close on June 25,
2018. Submit either electronic or written comments on this public
meeting by June 25, 2018. Please note that late, untimely filed
comments will not be considered. Electronic comments must be submitted
on or before June 25, 2018. The https://www.regulations.gov electronic
filing system will accept comments until midnight Eastern Time at the
end of June 25, 2018. Comments received by mail/hand delivery/courier
(for written/paper submissions) will be considered timely if they are
postmarked or the delivery service acceptance receipt is on or before
that date.
    Comments received on or before June 12, 2018, will be provided to
the committees. Comments received after that date will be taken into
consideration by FDA.
    You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2018-N-1797 for ``Joint Meeting of the Anesthetic and Analgesic
Drug Products Advisory Committee and the Drug Safety and Risk
Management Advisory Committee; Notice of Meeting; Establishment of a
Public Docket; Request for Comments.'' Received comments, those filed
in a timely manner (see ADDRESSES), will be placed in the docket and,
except for those submitted as ``Confidential Submissions,'' publicly
viewable at https://www.regulations.gov or at the Dockets Management
Staff between 9 a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' FDA will review
this copy, including the claimed confidential information, in its
consideration of comments. The second copy, which will have the claimed
confidential information redacted/blacked out, will be available for
public viewing and posted on https://www.regulations.gov. Submit both
copies to the Dockets Management Staff. If you do not wish your name
and contact information be made publicly available, you can provide
this information on the cover sheet and not in the body of your
comments and you must identify the information as ``confidential.'' Any
information marked as ``confidential'' will not be disclosed except in
accordance with 21 CFR 10.20 and other applicable disclosure law. For
more information about FDA's posting of comments to public dockets, see
80 FR 56469, September 18, 2015, or access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Yinghua Wang, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-
796-9001, Fax:<PHONE_NUMBER>, email: [email protected], or FDA Advisory
Committee Information Line, 1-800-741-8138<PHONE_NUMBER> in the

Washington, DC area). A notice in the Federal Register about last
minute modifications that impact a previously announced advisory
committee meeting cannot always be published quickly enough to provide
timely notice. Therefore, you should always check the FDA's website at
https://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to
the appropriate advisory committee meeting link, or call the advisory
committee information line to learn about possible modifications before
coming to the meeting.

SUPPLEMENTARY INFORMATION:
    Agenda: The committees will discuss new drug application 022324,
oxycodone extended-release capsules, submitted by Pain Therapeutics,
with the proposed indication of the management of pain severe enough to
require daily, around-the-clock, long-term opioid treatment and for
which alternative treatment options are inadequate. The product is
intended to have abuse-deterrent properties based on its
physicochemical properties. The committees will be asked to discuss
whether the data submitted by the Applicant are sufficient to support
labeling of the product with the properties expected to deter abuse.
    FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its website prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's website after the meeting. Background material is
available at https://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee meeting
link.
    Procedure: On June 26, 2018, from 9:30 a.m. to 5 p.m., the meeting
is open to the public. Interested persons may present data,
information, or views, orally or in writing, on issues pending before
the committees. All electronic and written submissions submitted to the
Docket (see ADDRESSES) on or before June 12, 2018, will be provided to
the committees. Oral presentations from the public will be scheduled
between approximately between 1:30 p.m. and 2:30 p.m. Those individuals
interested in making formal oral presentations should notify the
contact person and submit a brief statement of the general nature of
the evidence or arguments they wish to present, the names and addresses
of proposed participants, and an indication of the approximate time
requested to make their presentation on or before June 4, 2018. Time
allotted for each presentation may be limited. If the number of
registrants requesting to speak is greater than can be reasonably
accommodated during the scheduled open public hearing session, FDA may
conduct a lottery to determine the speakers for the scheduled open
public hearing session. The contact person will notify interested
persons regarding their request to speak by June 5, 2018.
    Closed Committee Deliberations: On June 26, 2018, from 8 a.m. to
9:30 a.m., the meeting will be closed to permit discussion and review
of trade secret and/or confidential commercial information (5 U.S.C.
552b(c)(4)). During this session, the committees will discuss the drug
development program of an investigational opioid formulation with
properties designed to deter abuse.
    Persons attending FDA's advisory committee meetings are advised
that FDA is not responsible for providing access to electrical outlets.
    For press inquiries, please contact the Office of Media Affairs at
[email protected] or<PHONE_NUMBER>.
    FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
disabilities. If you require accommodations due to a disability, please
contact Yinghua Wang (see FOR FURTHER INFORMATION CONTACT) at least 7
days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our website at https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures
on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: May 21, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-11166 Filed 5-23-18; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 75, Number 225 (Tuesday, November 23, 2010)]
[Rules and Regulations]
[Pages 71351-71353]
[FR Doc No: 2010-29451]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2010-0725; Directorate Identifier 2010-NE-18-AD];
Amendment 39-16528; AD 2010-24-09]
RIN 2120-AA64

Airworthiness Directives; Pratt & Whitney PW4000 Series Turbofan
Engines

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: We are adopting a new airworthiness directive (AD) for the
products listed above. This AD requires a one-time visual inspection of
the No. 3 bearing oil pressure tube, part number (P/N) 51J041-01, P/N
50J604-01, or P/N 50J924-01. Tubes that are found cracked or repaired
must be removed from service. This AD also prohibits repaired tubes
from being installed. This AD results from one report of a repaired No.
3 bearing oil tube that caused an engine in-flight shutdown, seven
reports of repaired No. 3 bearing oil pressure tubes found cracked that
led to unscheduled engine removals, and one report of a test cell event
from a repaired tube that cracked. We are issuing this AD to prevent
cracking of No. 3 bearing oil pressure tubes, which could result in
internal oil fire, failure of the high-pressure turbine (HPT) disks,
uncontained engine failure, and damage to the airplane.

DATES: This AD is effective December 28, 2010.

Examining the AD Docket

    You may examine the AD docket on the Internet at http://www.regulations.gov; or in person at the Docket Management Facility
between 9 a.m. and 5 p.m., Monday through Friday, except Federal
holidays. The AD docket contains this AD, the regulatory evaluation,
any comments received, and other information. The address for the
Docket Office (phone:<PHONE_NUMBER>) is Document Management Facility,
U.S. Department of Transportation, Docket Operations, M-30, West
Building Ground Floor, Room W12-140, 1200 New Jersey Avenue, SE.,
Washington, DC 20590.

FOR FURTHER INFORMATION CONTACT: James Gray, Aerospace Engineer, Engine
Certification Office, FAA, Engine and Propeller Directorate, 12 New
England Executive Park, Burlington, MA 01803; telephone<PHONE_NUMBER>;
fax<PHONE_NUMBER>; e-mail<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

Discussion

    We issued a notice of proposed rulemaking (NPRM) to amend 14 CFR
part 39 to include an airworthiness directive (AD) that would apply to
the specified products. That NPRM published in the Federal Register on
June 3, 2010 (75 FR 31330). That NPRM proposed to require:
     A one-time visual inspection of the No. 3 bearing oil
pressure tube, P/N 51J041-01, P/N 50J604-01, or P/N 50J924-01; and
     Removal from service if found cracked or repaired, or if
suspected that the tube was repaired; and
     A prohibition on installing repaired tubes.

Comments

    We gave the public the opportunity to participate in developing
this AD. The following presents the comments received on the proposal
and the FAA's response to each comment.

Request To Clarify Paragraph (e) of the Proposed AD

    United Airlines asked us to revise paragraph (e) of the proposed AD
to inspect the tube when the tube is in the piece-part condition.
United Airlines felt that changing paragraph (e) of the proposed AD
will make our intent clear.
    We agree. We revised paragraph (e) of the proposed AD to say ``You
are responsible for having the actions required by this AD performed
the next time the No. 3 bearing oil pressure tube is in the piece-part
condition after the effective date of this AD, unless the actions have
already been done.'' We also added a new heading ``Definitions'' and
new paragraph (i) that defines piece-part condition for the oil
pressure tube.

Request To Provide Clarification of the Definition of a Repair

    Delta Airlines, Inc. and United Airlines asked us to clarify the
types of repaired tubes that must be removed. Delta Airlines Inc. and
United Airlines said the body of the NPRM states that weld repairs were
the source of the failures.
    We don't agree. All repairs are unacceptable, not just weld
repairs. Further, the original equipment manufacturer also revised
their applicable repair manual(s) to remove all repairs to these tubes.

Conclusion

    We reviewed the relevant data, considered the comments received,
and determined that air safety and the public interest require adopting
the AD with the changes described previously and minor editorial
changes. We have determined that these minor changes:
     Are consistent with the intent that was proposed in the
NPRM for correcting the unsafe condition; and
     Do not add any additional burden upon the public than was
already proposed in the NPRM.
    We also determined that these changes will not increase the
economic burden on any operator or increase the scope of the AD.

Costs of Compliance

    We estimate that this AD would affect 973 PW4000 series turbofan
engines installed on airplanes of U.S. registry. We also estimate that
it would take about 10 minutes per engine to perform the one-time
visual inspection when the tube has been removed, and that the average
labor rate is $85 per work-hour. Required parts would cost about $9,154
per engine. Based on these figures, we estimate the total cost of the
AD to U.S. operators to be $8,923,383.

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. Subtitle VII: Aviation Programs,
describes in more detail the scope of the Agency's authority.
    We are issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701: ``General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.

Regulatory Findings

    This AD will not have federalism implications under Executive Order
13132. This AD will not have a substantial direct effect on the States,
on the relationship between the national government and the States, or
on the distribution of power and responsibilities among the various
levels of government.
    For the reasons discussed above, I certify that this AD:
    (1) Is not a ``significant regulatory action'' under Executive
Order 12866,
    (2) Is not a ``significant rule'' under DOT Regulatory Policies and
Procedures (44 FR 11034, February 26, 1979),
    (3) Will not affect intrastate aviation in Alaska, and
    (4) Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Safety.

Adoption of the Amendment

0
Accordingly, under the authority delegated to me by the Administrator,
the FAA amends 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority: 49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by adding the following new airworthiness
directive (AD):

2010-24-09 Pratt & Whitney: Amendment 39-16528; FAA-2010-0725;
Directorate Identifier 2010-NE-18-AD.

Effective Date

    (a) This AD is effective December 28, 2010.

Affected ADs

    (b) None.

Applicability

    (c) This AD applies to the following Pratt & Whitney turbofan
engines, with No. 3 bearing oil pressure tube, part number (P/N)
51J041-01, P/N 50J604-01, or P/N 50J924-01, installed:

PW4000-94'' Engines

    (1) PW4000-94'' engines affected are PW4050, PW4052, PW4056,
PW4060, PW4060A, PW4060C, PW4062, PW4062A, PW4152, PW4156, PW4156A,
PW4158, PW4160, PW4460, PW4462, and PW4650, including models with
any dash number suffix.

PW4000-100'' Engines

    (2) PW4000-100'' engines affected are PW4164, PW4168, PW4168A,
PW4164C, PW4164C/B, PW4170, PW4168A-1D, PW4168-1D, PW4164-1D,
PW4164C-1D, and PW4164C/B-1D, including models with any dash number
suffix.

PW4000-112'' Engines

    (3) PW4000-112'' engines affected are PW4074, PW4074D, PW4077,
PW4077D, PW4084, PW4084D, PW4090, PW4090-3, PW4090D, and PW4098,
including models with any dash number suffix.
    (4) These engines are installed on, but not limited to, Airbus
A300, A310, and A330 series, Boeing MD-11, 747, 767, and 777 series,
airplanes.

Unsafe Condition

    (d) This AD results from one report of a repaired No. 3 bearing
oil pressure tube that cracked and caused an engine in-flight
shutdown, one report of a test cell event, and seven reports since
2007, of repaired No. 3 bearing oil pressure tubes found cracked
that led to unscheduled engine removals. We are issuing this AD to
prevent cracking of No. 3 bearing oil pressure tubes, which could
result in internal oil fire, failure of the high-pressure turbine
disks, uncontained engine failure, and damage to the airplane.

Compliance

    (e) You are responsible for having the actions required by this
AD performed the next time the No. 3 bearing oil pressure tube is in
the piece-part condition after the

effective date of this AD, unless the actions have already been
done.

One-Time Visual Inspection of the No. 3 Bearing Oil Pressure Tube

    (f) Perform a one-time visual inspection of the exterior of the
No. 3 bearing oil pressure tube for cracks and evidence of being
repaired.
    (1) Remove the tube from service if any cracks are found.
    (2) Remove the tube from service if found repaired, or if
suspected that the tube was repaired.
    (g) After the effective date of this AD, do not install any
repaired No. 3 bearing oil pressure tube into any engine.
    (h) Guidance on the No. 3 bearing oil pressure tube visual
inspection can be found in:
    (1) Pratt & Whitney Clean, Inspect, Repair Manual PN 51A357, 72-
41-20 for PW4000-94'' and PW4000-100'' series engines; or
    (2) Pratt & Whitney Clean, Inspect, Repair Manual PN 51A750, 72-
41-20 for PW4000-112'' series engines.

Definitions

    (i) For the purpose of this AD, piece part condition means that
the part is completely disassembled from the engine as specified in
the disassembly instructions in the manufacturer's engine manual.

Alternative Methods of Compliance

    (j) The Manager, Engine Certification Office, FAA, may approve
alternative methods of compliance for this AD, if requested using
the procedures found in 14 CFR 39.19.

Related Information

    (k) For more information about this AD, contact James Gray,
Aerospace Engineer, Engine Certification Office, FAA, Engine and
Propeller Directorate, 12 New England Executive Park, Burlington, MA
01803; telephone<PHONE_NUMBER>; fax<PHONE_NUMBER>; e-mail:
<EMAIL_ADDRESS>
Material Incorporated by Reference

    (l) None.

    Issued in Burlington, Massachusetts, on November 16, 2010.
Robert G. Mann,
Acting Manager, Engine & Propeller Directorate, Aircraft Certification
Service.
[FR Doc. 2010-29451 Filed 11-22-10; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 77, Number 24 (Monday, February 6, 2012)]
[Proposed Rules]
[Pages 5724-5726]
[FR Doc No: 2012-2618]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2012-0039; Directorate Identifier 2011-NM-144-AD]
RIN 2120-AA64

Airworthiness Directives; Fokker Services B.V. Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: We propose to adopt a new airworthiness directive (AD) for
certain Fokker Services B.V. Model F.28 Mark 0070 and 0100 airplanes.
This proposed AD was prompted by reports of cracks underneath the
passenger door in a butt-joint on the forward fuselage of an F.28 Mark
0100 airplane. This proposed AD would require repetitive low frequency
eddy current inspections of the forward fuselage butt-joints for
cracks, and if necessary, a temporary repair followed by a permanent
repair. We are proposing this AD to detect and correct cracks on the
butt-joint on the forward fuselage, which could result in explosive
decompression and consequent loss of control of the airplane.

DATES: We must receive comments on this proposed AD by March 22, 2012.

ADDRESSES: You may send comments by any of the following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE., Washington, DC 20590.
     Hand Delivery: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
    For service information identified in this proposed AD, contact
Fokker Services B.V., Technical Services Dept., P.O. Box 231, 2150 AE
Nieuw-Vennep, the Netherlands; telephone +31 (0)252-627-350; fax +31
(0)252-627-211; email<EMAIL_ADDRESS>
Internet http://www.myfokkerfleet.com. You may review copies of the
referenced service information at the FAA, Transport Airplane
Directorate, 1601 Lind Avenue SW., Renton, Washington. For information
on the availability of this material at the FAA, call<PHONE_NUMBER>.

Examining the AD Docket

    You may examine the AD docket on the Internet at http://www.regulations.gov; or in person at the Docket Operations office
between 9 a.m. and 5 p.m., Monday through Friday, except Federal
holidays. The AD docket contains this proposed AD, the regulatory
evaluation, any comments received, and other information. The street
address for the Docket Operations office (telephone<PHONE_NUMBER>) is
in the ADDRESSES section. Comments will be available in the AD docket
shortly after receipt.

FOR FURTHER INFORMATION CONTACT: Tom Rodriguez, Aerospace Engineer,
International Branch, ANM-116, Transport Airplane Directorate, FAA 1601
Lind Avenue SW., Renton, Washington 98057-3356; telephone (425) 227-
1137; fax<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Comments Invited

    We invite you to send any written relevant data, views, or
arguments about this proposed AD. Send your comments to an address
listed under the ADDRESSES section. Include ``Docket No. FAA-2012-0039;
Directorate Identifier 2011-NM-144-AD'' at the beginning of

your comments. We specifically invite comments on the overall
regulatory, economic, environmental, and energy aspects of this
proposed AD. We will consider all comments received by the closing date
and may amend this proposed AD based on those comments.
    We will post all comments we receive, without change, to http://www.regulations.gov, including any personal information you provide. We
will also post a report summarizing each substantive verbal contact we
receive about this proposed AD.

Discussion

    The European Aviation Safety Agency (EASA), which is the Technical
Agent for the Member States of the European Community, has issued EASA
Airworthiness Directive 2011-0115, dated June 17, 2011 (referred to
after this as ``the MCAI''), to correct an unsafe condition for the
specified products. The MCAI states:

    A report has been received of a crack, detected in a butt-joint
on the forward fuselage of an F28 Mark 0100 aeroplane, underneath
the passenger door.
    Investigations revealed that, depending on the configuration of
the aeroplane, one or two butt-joints in the forward fuselage can be
affected.
    This condition, if not detected and corrected, could lead to
explosive decompression and consequent loss of the aeroplane.
    For the reasons described above, this [EASA] AD requires
repetitive [low frequency eddy current] inspections of the forward
fuselage butt joints for cracks and, when a crack is detected,
accomplishment of a temporary repair. This [EASA] AD also requires
reporting any cracks found to Fokker Services to enable the
development of a modification and the determination of an interval
for a repetitive inspection task, to be incorporated in the ALI
[airworthiness limitations instructions] section of the MRB
[maintenance review board] document. This [EASA] AD is considered to
be an interim measure and further AD action is likely.

Required actions include a permanent repair of the forward fuselage
butt-joints. You may obtain further information by examining the MCAI
in the AD docket.

Relevant Service Information

    Fokker Services B.V. has issued Service Bulletin SBF100-53-115,
dated June 16, 2011. The actions described in this service information
are intended to correct the unsafe condition identified in the MCAI.

FAA's Determination and Requirements of This Proposed AD

    This product has been approved by the aviation authority of another
country, and is approved for operation in the United States. Pursuant
to our bilateral agreement with the State of Design Authority, we have
been notified of the unsafe condition described in the MCAI and service
information referenced above. We are proposing this AD because we
evaluated all pertinent information and determined an unsafe condition
exists and is likely to exist or develop on other products of the same
type design.

Differences Between This AD and the MCAI or Service Information

    Paragraph (2) of EASA AD 2011-0115, dated June 17, 2011, explains
that an optional alternative method for the inspection required by
paragraph (g) of this proposed AD may be used. This AD does not include
that optional alternative method, as the service information in this AD
does not provide enough detail regarding this method.
    EASA AD 2011-0115, dated June 17, 2011, does not include a
permanent repair. This proposed AD does require a permanent repair.

Costs of Compliance

    Based on the service information, we estimate that this proposed AD
would affect about 4 products of U.S. registry. We also estimate that
it would take about 3 work-hours per product to comply with the basic
requirements of this proposed AD. The average labor rate is $85 per
work-hour. Based on these figures, we estimate the cost of the proposed
AD on U.S. operators to be $1,020, or $255 per product.
    In addition, we estimate that any necessary follow-on actions would
take about 40 work-hours and require parts costing $0, for a cost of
$3,400 per product. We have no way of determining the number of
products that may need these actions.

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. ``Subtitle VII: Aviation
Programs,'' describes in more detail the scope of the Agency's
authority.
    We are issuing this rulemaking under the authority described in
``Subtitle VII, Part A, Subpart III, Section 44701: General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.

Regulatory Findings

    We determined that this proposed AD would not have federalism
implications under Executive Order 13132. This proposed AD would not
have a substantial direct effect on the States, on the relationship
between the national Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
    For the reasons discussed above, I certify this proposed
regulation:
    1. Is not a ``significant regulatory action'' under Executive Order
12866;
    2. Is not a ``significant rule'' under the DOT Regulatory Policies
and Procedures (44 FR 11034, February 26, 1979); and
    3. Will not affect intrastate aviation in Alaska; and
    4. Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.
    We prepared a regulatory evaluation of the estimated costs to
comply with this proposed AD and placed it in the AD docket.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Proposed Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA proposes to amend 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

    1. The authority citation for part 39 continues to read as follows:

    Authority:  49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

    2. The FAA amends Sec.  39.13 by adding the following new AD:

Fokker Services B.V.: Docket No. FAA-2012-0039; Directorate
Identifier 2011-NM-144-AD.

(a) Comments Due Date

    We must receive comments by March 22, 2012.

(b) Affected ADs

    None.

(c) Applicability

    This AD applies to Fokker Services B.V. Model F.28 Mark 0070 and
0100 airplanes, as identified in Fokker Service Bulletin SBF100-53-
115, dated June 16, 2011.

(d) Subject

    Air Transport Association (ATA) of America Code 53: Fuselage.

(e) Reason

    This AD was prompted by reports of cracks underneath the
passenger door in a butt-joint on the forward fuselage of an F.28
Mark 0100 airplane. We are issuing this AD to detect and correct
cracks on the butt-joint on the forward fuselage, which could result
in explosive decompression and consequent loss of control of the
airplane.

(f) Compliance

    You are responsible for having the actions required by this AD
performed within the compliance times specified, unless the actions
have already been done.

(g) Inspection

    Before the accumulation of 20,000 total flight cycles, or within
180 flight cycles after the effective date of this AD, whichever
occurs later, do a low frequency eddy current inspection of the
forward fuselage butt-joints for cracks, in accordance with the
Accomplishment Instructions of Fokker Service Bulletin SBF100-53-
115, dated June 16, 2011. Repeat the inspection thereafter at
intervals not to exceed 1,000 flight cycles. Doing the temporary
repair in paragraph (h) of this AD is terminating action for the
repetitive inspections required by this paragraph. The temporary
repair can also be accomplished if no cracking is found.

(h) Temporary Repair

    If any cracking is found during any inspection required by
paragraph (g) of this AD, before further flight, do a temporary
repair, in accordance with the Accomplishment Instructions of Fokker
Service Bulletin SBF100-53-115, dated June 16, 2011. Doing the
temporary repair is terminating action for the repetitive
inspections required by paragraph (g) of this AD.

(i) Permanent Repair

    Within 10,000 flight cycles after installing the temporary
repair as required by paragraph (h) of this AD, install a permanent
repair using a method approved by the Manager, International Branch,
ANM 116, Transport Airplane Directorate, FAA.

(j) Reporting

    Submit a report of the findings (both positive and negative), to
Fokker Services B.V., Technical Services Dept., P.O. Box 231, 2150
AE Nieuw-Vennep, the Netherlands, using the reports form of Fokker
Service Bulletin SBF100-53-115, dated June 16, 2011, of the
inspection required by paragraph (g) of this AD, at the applicable
time specified in paragraph (j)(1) or (j)(2) of this AD.
    (1) If the inspection was done on or after the effective date of
this AD: Submit the report within 30 days after the inspection.
    (2) If the inspection was done before the effective date of this
AD: Submit the report within 30 days after the effective date of
this AD.

(k) Other FAA AD Provisions

    The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager,
International Branch, FAA, has the authority to approve AMOCs for
this AD, if requested using the procedures found in 14 CFR 39.19. In
accordance with 14 CFR 39.19, send your request to your principal
inspector or local Flight Standards District Office, as appropriate.
If sending information directly to the International Branch, send it
to ATTN: Tom Rodriguez, Aerospace Engineer, International Branch,
ANM-116, Transport Airplane Directorate, FAA 1601 Lind Avenue SW.,
Renton, Washington 98057-3356; telephone<PHONE_NUMBER>; fax (425)
227-1149. Information may be emailed to<EMAIL_ADDRESS>Before using any approved AMOC, notify your
appropriate principal inspector, or lacking a principal inspector,
the manager of the local flight standards district office/
certificate holding district office. The AMOC approval letter must
specifically reference this AD.
    (2) Airworthy Product: For any requirement in this AD to obtain
corrective actions from a manufacturer or other source, use these
actions if they are FAA-approved. Corrective actions are considered
FAA-approved if they are approved by the State of Design Authority
(or their delegated agent). You are required to assure the product
is airworthy before it is returned to service.
    (3) Reporting Requirements: A federal agency may not conduct or
sponsor, and a person is not required to respond to, nor shall a
person be subject to a penalty for failure to comply with a
collection of information subject to the requirements of the
Paperwork Reduction Act unless that collection of information
displays a current valid OMB Control Number. The OMB Control Number
for this information collection is 2120-0056. Public reporting for
this collection of information is estimated to be approximately 5
minutes per response, including the time for reviewing instructions,
completing and reviewing the collection of information. All
responses to this collection of information are mandatory. Comments
concerning the accuracy of this burden and suggestions for reducing
the burden should be directed to the FAA at: 800 Independence Ave.
SW., Washington, DC 20591, Attn: Information Collection Clearance
Officer, AES-200.

(l) Related Information

    Refer to MCAI European Aviation Safety Agency Airworthiness
Directive 2011-0115, dated June 17, 2011; and Fokker Service
Bulletin SBF100-53-115, dated June 16, 2011; for related
information.

    Issued in Renton, Washington, on January 12, 2012.
Michael J. Kaszycki,
Acting Manager, Transport Airplane Directorate, Aircraft Certification
Service.
[FR Doc. 2012-2618 Filed 2-3-12; 8:45 am]
BILLING CODE 4910-13-P